Phenominer Database Results (8 results)

 
 
Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Record ID Study ID
SD heart left ventricle end-diastolic diameter artificial aortocaval fistula (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male  days 6 8.1 mm 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 ACF 2 days 98846 2160
SD heart left ventricle end-diastolic diameter sham surgical control condition (between 120 and 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male  days 6 7.1 mm 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 sham ACF 5 days 98849 2160
SD heart left ventricle end-diastolic diameter artificial aortocaval fistula (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male  days 6 7.8 mm 0.4 0.98 HP Sonos 5500 echo ultrasound 1.0 ACF 720 min 98844 2160
SD heart left ventricle end-diastolic diameter sham surgical control condition (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male  days 6 7.2 mm 0.3 0.73 HP Sonos 5500 echo ultrasound 1.0 sham ACF 360 min 98843 2160
SD heart left ventricle end-diastolic diameter artificial aortocaval fistula (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male  days 6 7.4 mm 0.3 0.73 HP Sonos 5500 echo ultrasound 1.0 ACF 360 min 98842 2160
SD heart left ventricle end-diastolic diameter sham surgical control condition (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male  days 6 7.3 mm 0.3 0.73 HP Sonos 5500 echo ultrasound 1.0 sham ACF 720 min 98845 2160
SD heart left ventricle end-diastolic diameter sham surgical control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male  days 6 7.1 mm 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 sham ACF 2 days 98847 2160
SD heart left ventricle end-diastolic diameter artificial aortocaval fistula (for 5 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male  days 6 7.9 mm 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 ACF 5 days 98848 2160